Senolytics Treatment of Interstitial Lung Disease in Common Variable

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03663933` - Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation	Phase 2
Recruiting	`NCT01652092` - Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies	N/A
Recruiting	`NCT05321407` - COVID-19 Vaccine Responses in PIDD Subjects
Recruiting	`NCT04339777` - Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity	Phase 2
Completed	`NCT00542997` - Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy	Phase 3
Completed	`NCT00168025` - Efficacy and Safety of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)	Phase 3
Completed	`NCT00168012` - Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID)	Phase 3
Completed	`NCT00004695` - Randomized Study of Polyethylene-Glycol-Conjugated Interleukin 2 in Patients With Common Variable Immunodeficiency	N/A
Completed	`NCT01196702` - Lymphocyte Immunophenotyping in Common Variable Immunodeficiency
Recruiting	`NCT06355323` - Bronchiectasis Prevalence in Patients With Primary Humoral Immunodefiency in Champagne-Ardenne Region, France	N/A
Completed	`NCT00322556` - Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)	Phase 3
Recruiting	`NCT02579967` - Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies	Phase 2
Recruiting	`NCT06145100` - Prediction of Portal Hypertension in Patients With CVID (CVID-pHT)
Completed	`NCT01289847` - A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency	Phase 4
Completed	`NCT00520494` - Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency	Phase 4
Terminated	`NCT00006054` - Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies	N/A
Completed	`NCT03211689` - The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency Disease	N/A
Terminated	`NCT01489618` - "Prime Boost" Vaccination Strategy Combining Conjugated Anti- Pneumococcal Vaccine (s0) and Polysaccharide Anti- Pneumococcal Vaccine (s4) Compared to Polysaccharide Anti- Pneumococcal Vaccine Alone (s4) In Patients With Common Variable Immunodeficiency	Phase 2
Completed	`NCT03513328` - Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation	Phase 1/Phase 2
Completed	`NCT03188419` - Breadth of Donor Options for People With Inherited Diseases Requiring Allogeneic Hematopoietic Stem Cell Transplant in the Era of Alternative Donor Transplants Using Post-Transplantation Cyclophosphamide

NCT number	NCT05593588
Study type	Interventional
Source	Mayo Clinic
Contact
Status	Enrolling by invitation
Phase	Phase 2
Start date	April 12, 2023
Completion date	December 2026

Senolytics Treatment of Interstitial Lung Disease in Common Variable Immunodeficiency

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms